NCT02778100 - A Study of Nasal Glucagon in Participants With a Common Cold | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions

Common Cold

Interventions

DRUG

Nasal Glucagon

Administered intranasally.

DRUG

Oxymetazoline

Administered intranasally.

Trial Locations (1)

H3P 3P1

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Mount Royal